Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC461614071;14072;14073 chr2:178739387;178739386;178739385chr2:179604114;179604113;179604112
N2AB429913120;13121;13122 chr2:178739387;178739386;178739385chr2:179604114;179604113;179604112
N2ANoneNone chr2:Nonechr2:None
N2B425312982;12983;12984 chr2:178739387;178739386;178739385chr2:179604114;179604113;179604112
Novex-1437813357;13358;13359 chr2:178739387;178739386;178739385chr2:179604114;179604113;179604112
Novex-2444513558;13559;13560 chr2:178739387;178739386;178739385chr2:179604114;179604113;179604112
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTT
  • RefSeq wild type template codon: CAA
  • Domain: Ig-29
  • Domain position: 11
  • Structural Position: 14
  • Q(SASA): 0.4666
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/I rs1008595479 None None N 0.082 0.118 None gnomAD-4.0.0 1.59114E-06 None None None None N None 0 2.28655E-05 None 0 0 None 0 0 0 0 0
V/L rs1008595479 -0.117 0.002 N 0.14 0.112 None gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.9E-06 0
V/L rs1008595479 -0.117 0.002 N 0.14 0.112 None gnomAD-4.0.0 1.59114E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85801E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.106 likely_benign 0.1312 benign -0.42 Destabilizing 0.005 N 0.139 neutral N 0.496774334 None None N
V/C 0.4803 ambiguous 0.5916 pathogenic -0.687 Destabilizing 0.356 N 0.305 neutral None None None None N
V/D 0.1506 likely_benign 0.1952 benign -0.076 Destabilizing 0.055 N 0.375 neutral N 0.511169099 None None N
V/E 0.1339 likely_benign 0.1725 benign -0.188 Destabilizing 0.072 N 0.283 neutral None None None None N
V/F 0.0904 likely_benign 0.1045 benign -0.628 Destabilizing 0.171 N 0.369 neutral N 0.515041149 None None N
V/G 0.1422 likely_benign 0.1805 benign -0.545 Destabilizing 0.012 N 0.267 neutral N 0.516008522 None None N
V/H 0.269 likely_benign 0.3741 ambiguous -0.116 Destabilizing 0.628 D 0.285 neutral None None None None N
V/I 0.0605 likely_benign 0.0648 benign -0.246 Destabilizing None N 0.082 neutral N 0.43879056 None None N
V/K 0.1508 likely_benign 0.2133 benign -0.371 Destabilizing 0.001 N 0.19 neutral None None None None N
V/L 0.1057 likely_benign 0.131 benign -0.246 Destabilizing 0.002 N 0.14 neutral N 0.501353426 None None N
V/M 0.0898 likely_benign 0.0996 benign -0.326 Destabilizing 0.214 N 0.28 neutral None None None None N
V/N 0.1092 likely_benign 0.1536 benign -0.167 Destabilizing 0.072 N 0.374 neutral None None None None N
V/P 0.3424 ambiguous 0.4897 ambiguous -0.27 Destabilizing 0.136 N 0.365 neutral None None None None N
V/Q 0.1666 likely_benign 0.2226 benign -0.39 Destabilizing 0.214 N 0.377 neutral None None None None N
V/R 0.1328 likely_benign 0.1795 benign 0.106 Stabilizing 0.038 N 0.407 neutral None None None None N
V/S 0.0988 likely_benign 0.1289 benign -0.557 Destabilizing None N 0.119 neutral None None None None N
V/T 0.0801 likely_benign 0.0917 benign -0.566 Destabilizing None N 0.107 neutral None None None None N
V/W 0.5324 ambiguous 0.6122 pathogenic -0.703 Destabilizing 0.864 D 0.305 neutral None None None None N
V/Y 0.2689 likely_benign 0.3364 benign -0.4 Destabilizing 0.356 N 0.349 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.